Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Constructing disease management programs for glaucoma.

Lawrence D Goldberg

    Managed Care (Langhorne, Pa.)
    |September 11, 2004
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A single center, pilot, double-blinded, randomized, comparative, prospective clinical study to evaluate improvements in the structure and function of facial skin with tazarotene 0.1% cream alone and in combination with GliSODin(®) Skin Nutrients Advanced Anti-Aging Formula.

    Clinical, cosmetic and investigational dermatology·2014
    Same author

    The convergence of psoriasis treatment cost-effectiveness over time: "real world" considerations in economic modeling.

    Journal of the American Academy of Dermatology·2008
    Same author

    Current management of glaucoma and the need for complete therapy.

    The American journal of managed care·2008
    Same author

    Managing insomnia in an evolving marketplace.

    The American journal of managed care·2006
    Same author

    Cost considerations in the medical management of glaucoma in the US: estimated yearly costs and cost effectiveness of bimatoprost compared with other medications.

    PharmacoEconomics·2006
    Same author

    The cost of migraine and its treatment.

    The American journal of managed care·2005
    Same journal

    Thanks to CMS Rule Change, MA Takes SDOH to a Whole New Level.

    Managed care (Langhorne, Pa.)·2019
    Same journal

    Hail, Not Frail! MA's Wellness Reach Expands.

    Managed care (Langhorne, Pa.)·2019
    Same journal

    To Be Continued:The Search for a Cure for HIV.

    Managed care (Langhorne, Pa.)·2019
    Same journal

    Once-a-day HIV Treatment: Pricey But Perhaps Worth It.

    Managed care (Langhorne, Pa.)·2019
    Same journal

    In Trump, HIV/AIDS Groups Find an Ally Who's Tough To Love.

    Managed care (Langhorne, Pa.)·2019
    Same journal

    Air Ambulance Turbulence: Consolidation, Cost Shifting, and Surprise Billing.

    Managed care (Langhorne, Pa.)·2019
    See all related articles

    Glaucoma management is beneficial for patients with diabetes, hypertension, and hypothyroidism. This article guides clinicians on establishing disease management (DM) programs for effective glaucoma identification and treatment.

    Area of Science:

    • Ophthalmology
    • Public Health

    Background:

    • Glaucoma is a progressive optic neuropathy.
    • Associated conditions include diabetes, hypertension, and hypothyroidism.
    • Glaucoma is a suitable condition for disease management.

    Purpose of the Study:

    • To inform clinicians and administrators about glaucoma disease management (DM).
    • To highlight the benefits of establishing a DM program for glaucoma.
    • To guide the identification and treatment of glaucoma through DM.

    Main Methods:

    • This article provides an overview of disease management principles.
    • It focuses on the application of DM to glaucoma care.
    • Information is targeted towards healthcare professionals and administrators.

    Related Experiment Videos

    Main Results:

    • Disease management programs can improve glaucoma care.
    • Early identification and treatment are key components of effective DM.
    • Clinicians and administrators can benefit from implementing DM strategies.

    Conclusions:

    • Establishing a disease management program for glaucoma is recommended.
    • DM programs can enhance patient outcomes for glaucoma.
    • Healthcare providers should consider DM for managing glaucoma and its comorbidities.